Refractory Ocular Behçet’s Disease; Outcome of Low Dose Infliximab

Rheumatology Research
doi 10.22631/rr.2019.69997.1070
Full Text
Abstract

Available in full text

Date
Authors
Publisher

eJournalPlus

Related search

Low Dose Interleukin-2 for Refractory Autoimmune Hepatitis

Hepatology
MedicineHepatology
2018English

Outcomes of Infliximab in Management of Steroid-Refractory Acute Graft Versus Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Vascular Manifestations of Behçet’s Disease

2017English

Correlation Between Elevation of Serum Antinuclear Antibody Titer and Decreased Therapeutic Efficacy in the Treatment of Behçet’s Disease With Infliximab

Graefe's Archive for Clinical and Experimental Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2012English

Lungs Damage in Behçet’s Disease

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2009English

Analysis of the Association Between Fc Receptor Family Gene Polymorphisms and Ocular Behçet’s Disease in Han Chinese

Scientific Reports
Multidisciplinary
2018English

Mucocutaneous Findings in Behçet’s Disease

2017English

Successful Treatment of Refractory Behçet’s Myositis With Tumor Necrosis Factor Inhibitor

Hong Kong Bulletin on Rheumatic Diseases
2018English

Effects of Low-Dose Infliximab on Spinal Inflammation on Magnetic Resonance Imaging in Ankylosing Spondylitis

Journal of Rheumatology
RheumatologyAllergyImmunology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy